A comparative analysis of the aggregation behavior of amyloid-β peptide variants (original) (raw)

FEBS Letters, 2012

Abstract

Aggregated forms of the amyloid-β peptide are hypothesized to act as the prime toxic agents in Alzheimer disease (AD). The in vivo amyloid-β peptide pool consists of both C- and N-terminally truncated or mutated peptides, and the composition thereof significantly determines AD risk. Other variations, such as biotinylation, are introduced as molecular tools to aid the understanding of disease mechanisms. Since these modifications have the potential to alter key aggregation properties of the amyloid-β peptide, we present a comparative study of the aggregation of a substantial set of the most common in vivo identified and in vitro produced amyloid-β peptides.

Kerensa Broersen hasn't uploaded this paper.

Let Kerensa know you want this paper to be uploaded.

Ask for this paper to be uploaded.